Income StatementBalance SheetCash FlowSegments
COA

Hemab Therapeutics Holdings, Inc. Common Stock Business Segments

Business, geographic, and product segment breakdowns
Hmb002$3.5MSutacimig$5.8M

Products & Services

Research And Development Expense Excluding Acquired In Process Cost

SegmentQ1 '25Q1 '26
Sutacimig$6.0M$5.8M
Hmb002$4.6M$3.5M

Geographic

Non-Current Assets

SegmentQ1 '25Q1 '26
DK$1.6M$1.2M
US$786.0K$348.0K